| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Anatomical and Cellular Pathology [K-W. L., S-T. C., Y-S. T., K-F. M., Y-F. C., J. C. K. L., D. P. H.], Clinical Oncology [S-F. L.], and Surgery [A. v. H., J. K. S. W.], Division of Otorhinolaryngology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N. T., Hong Kong
We have recently reported that inactivation of the p16 gene by mutation and deletion is common in nasopharyngeal carcinoma (NPC). The present study demonstrates that hypermethylation of the 5' CpG island can serve as an alternative mechanism for inactivation of the p16 gene in this tumor. Using Southern blotting analysis and multiplex PCR, aberrant methylation of the 5' CpG island of the p16 gene was found in a NPC xenograft (xeno-666) and 6 (22%) of 27 primary tumors, but not in normal tissues of the nasopharynx. In the NPC xenograft (xeno-666) and its newly derived cell line (cell-666), both showing hypermethylation of the p16 gene, no p16 gene expression was found. After treatment with 5-aza-2'-deoxycytidine, reexpression of the p16 gene was detected in the cell line cell-666. These findings suggest that aberrant methylation of the 5' CpG island may participate in the transcriptional inactivation of the p16 gene in NPC. The present results further support that the p16 gene is the critical target on chromosome 9p21 for inactivation during the development of this disease.
1 Supported by a research grant (Hong Kong Grant CUHK52/93M) from the University and Polytechnic Grants Committee, Hong Kong.
2 To whom requests for reprints should be addressed. Phone: (852) 2632-1136; Fax: (852) 2637-6274.
Received 3/25/96. Accepted 4/30/96.
This article has been cited by other articles:
![]() |
K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas Ann. Onc., October 1, 2008; 19(10): 1774 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang and H.-O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1765 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stevenson, C. Charalambous, and J. B. Wilson Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9 Cancer Res., October 1, 2005; 65(19): 8826 - 8835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B.-Y. Hui, Y. Y.-Y. Or, H. Takano, R. K.-Y. Tsang, K.-F. To, X.-Y. Guan, J. S.-T. Sham, K. W.-K. Hung, C. N.-Y. Lam, C. A. van Hasselt, et al. Array-Based Comparative Genomic Hybridization Analysis Identified Cyclin D1 as a Target Oncogene at 11q13.3 in Nasopharyngeal Carcinoma Cancer Res., September 15, 2005; 65(18): 8125 - 8133. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al. Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. C. Lee, J.-H. Li, W. Shi, A. Li, E. Ng, T.-J. Liu, H. J. Klamut, and F.-F. Liu p16 Gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma Mol. Cancer Ther., October 1, 2003; 2(10): 961 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Wong, D. L.-W. Kwong, J. S.-T. Sham, S. W. Tsao, W. I. Wei, Y. L. Kwong, and A. P.-W. Yuen Promoter Hypermethylation of High-in-normal 1 Gene in Primary Nasopharyngeal Carcinoma Clin. Cancer Res., August 1, 2003; 9(8): 3042 - 3046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Macdiarmid, D. Stevenson, D. H. Campbell, and J. B. Wilson The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo Carcinogenesis, July 1, 2003; 24(7): 1209 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Makitie, C. MacMillan, J. Ho, W. Shi, A. Lee, B. O'Sullivan, D. Payne, M. Pintilie, B. Cummings, J. Waldron, et al. Loss of p16 Expression Has Prognostic Significance in Human Nasopharyngeal Carcinoma Clin. Cancer Res., June 1, 2003; 9(6): 2177 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Hwang, C.-L. Cho, C.-C. Huang, J.-S. Wang, Y.-L. Shih, C.-Y. Su, and H.-W. Chang Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy Ann. Onc., August 1, 2002; 13(8): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, and Y.-S. Chang The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases PNAS, July 23, 2002; 99(15): 10084 - 10089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. C. Chan, P. M. L. Teo, and P. J. Johnson Nasopharyngeal carcinoma Ann. Onc., July 1, 2002; 13(7): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sze Wong, H. Wen Chang, K. Chi Tang, W. Ignace Wei, D. Lai Wen Kwong, J. Shun Tong Sham, A. Po Wing Yuen, and Y. Lam Kwong High Frequency of Promoter Hypermethylation of the Death-associated Protein-Kinase Gene in Nasopharyngeal Carcinoma and Its Detection in the Peripheral Blood of Patients Clin. Cancer Res., February 1, 2002; 8(2): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Y. Chan, L. W. Chan, N. L. S. Tang, J. H. M. Tong, K. W. Lo, T. L. Lee, H. Y. Cheung, W. S. Wong, P. S. F. Chan, F. M. M. Lai, et al. Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients Clin. Cancer Res., February 1, 2002; 8(2): 464 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kwong, K.-W. Lo, K.-F. To, P. M. L. Teo, P. J. Johnson, and D. P. Huang Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma Clin. Cancer Res., January 1, 2002; 8(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Fang, J. A. Mikovits, R. Bagni, C. L. Petrow-Sadowski, and F. W. Ruscetti Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation J. Virol., October 15, 2001; 75(20): 9753 - 9761. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Lo, J. Kwong, A. B.-Y. Hui, S. Y.-Y. Chan, K.-F. To, A. S.-C. Chan, L. S.-N. Chow, P. M. L. Teo, P. J. Johnson, and D. P. Huang High Frequency of Promoter Hypermethylation of RASSF1A in Nasopharyngeal Carcinoma Cancer Res., May 1, 2001; 61(10): 3877 - 3881. [Abstract] [Full Text] |
||||
![]() |
K.-W. Lo, P. M. L. Teo, A. B.-Y. Hui, K.-F. To, Y.-S. Tsang, S. Y.-Y. Chan, K.-F. Mak, J. C. K. Lee, and D. P. Huang High Resolution Allelotype of Microdissected Primary Nasopharyngeal Carcinoma Cancer Res., July 1, 2000; 60(13): 3348 - 3353. [Abstract] [Full Text] |
||||
![]() |
F. Sbih-Lammali, B. Clausse, H. Ardila-Osorio, R. Guerry, M. Talbot, S. Havouis, L. Ferradini, J. Bosq, T. Tursz, and P. Busson Control of Apoptosis in Epstein Barr Virus-positive Nasopharyngeal Carcinoma Cells: Opposite Effects of CD95 and CD40 Stimulation Cancer Res., February 1, 1999; 59(4): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Lantry, Z. Zhang, K. A. Crist, Y. Wang, G. J. Kelloff, R. A. Lubet, and M. You 5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model Carcinogenesis, February 1, 1999; 20(2): 343 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kuerbitz, J. Malandro, N. Compitello, S. B. Baylin, and J. R. Graff Deletion of p16INK4A/CDKN2 and p15INK4B in Human Somatic Cell Hybrids and Hybrid-derived Tumors Cell Growth Differ., January 1, 1999; 10(1): 27 - 33. [Abstract] [Full Text] |
||||
![]() |
X. Qian, L. Jin, E. Kulig, and R. V. Lloyd DNA Methylation Regulates p27Kip1 Expression in Rodent Pituitary Cell Lines Am. J. Pathol., November 1, 1998; 153(5): 1475 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Klangby, I. Okan, K. P. Magnusson, M. Wendland, P. Lind, and K. G. Wiman p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma Blood, March 1, 1998; 91(5): 1680 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H.L. Ng, Y.F. Chung, K.W. Lo, N.W.R. Wickham, J.C.K. Lee, and D.P. Huang Frequent Hypermethylation of p16 and p15 Genes in Multiple Myeloma Blood, April 1, 1997; 89(7): 2500 - 2506. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |